Helen Louise Collins's Net Worth
$5.96 Million
Who is Helen Louise Collins?
Helen Louise Collins has an estimated net worth of $5.96 Million. This is based on reported shares across multiple companies, which include Kura Oncology, Inc., Enliven Therapeutics, Inc., FIVE PRIME THERAPEUTICS, INC., and IO Biotech, Inc..
SEC CIK
Helen Louise Collins's CIK is 0001701247
Past Insider Trading and Trends
2020 was Helen Louise Collins's most active year for acquiring shares with 6 total transactions. Helen Louise Collins's most active month to acquire stocks was the month of January. 2021 was Helen Louise Collins's most active year for disposing of shares, totalling 11 transactions. Helen Louise Collins's most active month to dispose stocks was the month of January. 2023 saw Helen Louise Collins paying a total of $0.00 for 583,322 shares, this is the most they've acquired in one year. In 2021 Helen Louise Collins cashed out on 519,534 shares for a total of $5,345,569.19, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Kura Oncology, Inc. (KURA) Snapshot price: $20.7
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Enliven Therapeutics, Inc. (ELVN) Snapshot price: $15.51
CHIEF MEDICAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$13.78 | -$451,878.00 |
0
|
Scheduled
|
Apr 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
FIVE PRIME THERAPEUTICS, INC. No price found
EVP and Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -77.63K |
$38.00 | -$5,150,786.00 |
0
|
Mar 31 - Apr 16
| |||
Form 4
| -1.47% | -1.16K |
$22.23 | -$25,742.34 | 77.63K |
Feb 26
| |||
Form 4
| -7.88% | -6.74K |
$25.07 | -$169,040.85 | 78.79K |
Feb 24 - Feb 25
| |||
Form 4
| +13.87% | 10.42K |
$16.14 | -$186,949.62 | 85.53K |
Dec 11
| |||
Form 4
| +17.08% | 10.96K |
$18.00 | -$198,702.00 | 75.12K |
Nov 11
| |||
Form 4
| -1.27% | -827.00 |
$4.69 | -$3,878.63 | 64.16K |
Aug 20
| |||
Form 4
| -1.26% | -827.00 |
$2.30 | -$1,902.10 | 64.98K |
Mar 20
| |||
Form 4
| +68.95% | 26.86K |
$4.85 | -$15,255.17 | 65.81K |
Feb 24 - Feb 26
| |||
Form 4
| -12.07% | -5.34K |
$5.13 | -$27,419.85 | 38.95K |
Feb 5
| |||
Form 4
| -1.11% | -496.00 |
$5.43 | -$2,693.28 | 44.3K |
Sep 1
| |||
Form 4
| +12.56% | 5K |
—
|
—
| 44.79K |
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +28.49% | 8.82K |
$11.95 | -$14,065.15 | 39.79K |
Feb 25 - Feb 26
| |||
Form 4
| -9.35% | -3.20K |
$11.43 | -$36,530.28 | 30.97K |
Feb 5
| |||
Form 4
| +6.01% | 1.94K |
$13.92 | -$26,531.52 | 34.17K |
Sep 28
| |||
Form 4
| -1.52% | -496.00 |
$14.00 | -$6,944.00 | 32.23K |
Sep 1
| |||
Form 4
| -3.65% | -1.24K |
$17.38 | -$21,551.20 | 32.73K |
Jun 23
| |||
Form 4
| -2.38% | -827.00 |
$16.26 | -$13,447.02 | 33.97K |
Mar 20
| |||
Form 4
| +21.09% | 6.06K |
$31.24 | -$29,365.60 | 34.79K |
Jun 23 - Feb 26
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -4.23% | -1.05K |
$18.42 | -$19,304.16 | 23.73K |
Feb 5
| |||
Form 4
| -1.49% | -376.00 |
$34.34 | -$12,911.84 | 24.78K |
Sep 1
| |||
Form 4
| +5.23% | 1.25K |
—
|
—
| 25.16K |
Apr 24
| |||
Form 4
| +18.60% | 3.75K |
—
|
—
| 23.91K |
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IO Biotech, Inc. (IOBT) Snapshot price: $1.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||